Abstract：
:Narcolepsy type 1 and narcolepsy type 2 are central disorders of hypersomnolence. Narcolepsy type 1 is characterized by excessive daytime sleepiness and cataplexy and is associated with hypocretin-1 deficiency. On the other hand, in narcolepsy type 2, cerebrospinal fluid hypocretin-1 levels are normal and cataplexy absent. Despite major advances in our understanding of narcolepsy mechanisms, its current management is only symptomatic. Treatment options may vary from a single drug that targets several symptoms, or multiple medications that each treats a specific symptom. In recent years, narcolepsy treatment has changed with the widespread use of modafinil/armodafinil for daytime sleepiness, antidepressants (selective serotonin and dual serotonin and noradrenalin reuptake inhibitors) for cataplexy, and sodium oxybate for both symptoms. Other psychostimulants can also be used, such as methylphenidate, pitolisant and rarely amphetamines, as third-line therapy. Importantly, clinically relevant subjective and objective measures of daytime sleepiness are required to monitor the treatment efficacy and to provide guidance on whether the treatment goals are met. Associated symptoms and comorbid conditions, such as hypnagogic/hypnopompic hallucinations, sleep paralysis, disturbed nighttime sleep, unpleasant dreams, REM- and non REM-related parasomnias, depressive symptoms, overweight/obesity, and obstructive sleep apnea, should also be taken into account and managed, if required. In the near future, the efficacy of new wake-promoting drugs, anticataplectic agents, hypocretin replacement therapy and immunotherapy at the early stages of the disease should also be evaluated.
journal_name
CNS Drugsjournal_title
CNS drugsauthors
Barateau L,Lopez R,Dauvilliers Ydoi
10.1007/s40263-016-0337-4subject
Has Abstractpub_date
2016-05-01 00:00:00pages
369-79issue
5eissn
1172-7047issn
1179-1934pii
10.1007/s40263-016-0337-4journal_volume
30pub_type
杂志文章,评审相关文献
CNS DRUGS文献大全abstract：BACKGROUND:Antidepressant-induced liver injury is a major concern and a liver monitoring scheme has been recommended by the European Medicines Agency for agomelatine. OBJECTIVE:The objective of this study was to assess the liver safety and identify the characteristics of patients who developed a significant increase i...
journal_title：CNS drugs
pub_type： 杂志文章,meta分析
doi：10.1007/s40263-016-0351-6
更新日期：2016-09-01 00:00:00
abstract：:Aripiprazole (Abilify(®)) is an atypical antipsychotic that is widely used in the treatment of psychiatric conditions. Unlike other currently available atypical antipsychotics that primarily have varying degrees of dopamine D2 receptor antagonism, aripiprazole is a partial agonist at D2 and serotonin 5-HT1A receptors,...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-013-0134-2
更新日期：2014-02-01 00:00:00
abstract：:▴ Ziprasidone is a novel antipsychotic drug. It has high affinity for serotonin 5-HT(2) and dopamine D(2) receptors in vitro, with an 11-fold higher affinity for 5-HT(2) than for D(2) receptors, suggestive of a low potential for inducing motor disturbance [including extrapyramidal symptoms (EPS)].▴ The effects of zipr...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.2165/00023210-199708020-00006
更新日期：1997-08-01 00:00:00
abstract：:The aim of this review is to provide clinicians with a picture of the mechanisms by which: histamine and histaminergic agonists act on the vestibular system both peripherally and centrally; and histaminergic agonists and antagonists interfere with the recovery process after peripheral vestibular lesion. We have focuse...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200115110-00004
更新日期：2001-01-01 00:00:00
abstract：BACKGROUND:Statin use has been frequently associated with depressive symptoms in an older population. However, the nature of this association is uncertain in the literature. In this study, we aimed to investigate the association of statin intake and the prevalence of depressive symptoms in healthy community-dwelling ol...
journal_title：CNS drugs
pub_type： 杂志文章,随机对照试验
doi：10.1007/s40263-019-00633-3
更新日期：2019-07-01 00:00:00
abstract：BACKGROUND:Valproate is a first-line antiepileptic agent and is also used in the treatment of bipolar disorder and migraine. It is a known human teratogen. The objective of the study was to evaluate the teratogenic risk of valproate. METHODS:All callers who contacted the Israeli Teratology Information Service (TIS) be...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.2165/00023210-200822040-00004
更新日期：2008-01-01 00:00:00
abstract：BACKGROUND AND OBJECTIVE:Patients with focal seizures recruited into adjunctive antiepileptic drug (AED) trials have become more refractory and severe over time; concurrently, placebo responses have increased. To attempt to account for heterogeneity among trials, propensity-score weighted patient-level data were used t...
journal_title：CNS drugs
pub_type： 杂志文章,随机对照试验
doi：10.1007/s40263-017-0462-8
更新日期：2017-10-01 00:00:00
abstract：:Hashimoto's encephalopathy is a term used to describe an encephalopathy of presumed autoimmune origin characterised by high titres of antithyroid peroxidase antibodies. In a similar fashion to autoimmune thyroid disease, Hashimoto's encephalopathy is more common in women than in men. It has been reported in paediatric...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200721100-00002
更新日期：2007-01-01 00:00:00
abstract：BACKGROUND:Several small studies have shown beneficial effects of ondansetron, a serotonin 5-HT(3) receptor antagonist, in the treatment of obsessive-compulsive disorder (OCD). The efficacy of other 5-HT(3) receptor antagonists in patients with OCD is still unclear. Granisetron does not alter cytochrome P450 activity a...
journal_title：CNS drugs
pub_type： 临床试验,杂志文章,多中心研究,随机对照试验
doi：10.2165/11635850-000000000-00000
更新日期：2012-10-01 00:00:00
abstract：BACKGROUND:Walking impairment is a hallmark of multiple sclerosis (MS). It affects > 90% of individuals over time, reducing independence and negatively impacting health-related quality of life, productivity, and daily activities. Walking impairment is consistently reported as one of the most distressing impairments by ...
journal_title：CNS drugs
pub_type： 杂志文章,多中心研究,随机对照试验
doi：10.1007/s40263-018-0586-5
更新日期：2019-01-01 00:00:00
abstract：:Levetiracetam (Keppra®, E Keppra®) is an established second-generation antiepileptic drug (AED). Worldwide, levetiracetam is most commonly approved as adjunctive treatment of partial-onset seizures with or without secondary generalization; other approved indications include monotherapy treatment of partial-onset seizu...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/11208340-000000000-00000
更新日期：2011-10-01 00:00:00
abstract：:Neuropathic pain is a persistent pain condition that develops secondary to nerve injury. The two most common types of peripheral neuropathic pain are post-herpetic neuralgia (PHN) and painful diabetic neuropathy (PDN). Amitriptyline, nortriptyline, desipramine and imipramine are TCAs that have been shown to be effecti...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200822050-00005
更新日期：2008-01-01 00:00:00
abstract：OBJECTIVE:Many authors have reported discontinuation symptoms associated with selective serotonin reuptake inhibitors (SSRIs). The aim of this study was to investigate the incidence and characteristics of the discontinuation syndrome in patients who stopped treatment with the SSRIs paroxetine and fluoxetine under the u...
journal_title：CNS drugs
pub_type： 临床试验,杂志文章
doi：10.2165/00023210-200216040-00006
更新日期：2002-01-01 00:00:00
abstract：BACKGROUND:There is growing epidemiological evidence that opioids may increase the risk of unintentional injuries and it is plausible that the time of initiation is most critical in that respect. Studies on fall-related injuries remain few, limited and mostly focused on specific groups of elderly patients. OBJECTIVE:T...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.1007/s40263-013-0038-1
更新日期：2013-02-01 00:00:00
abstract：:Lacosamide (Vimpat(®)) is a functionalized amino acid available orally (as a syrup or tablet) and as an intravenous infusion. It is believed to exert its antiepileptic effect by selectively enhancing the slow inactivation of voltage-gated sodium channels. Lacosamide is approved in several countries worldwide as an adj...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-013-0123-5
更新日期：2013-12-01 00:00:00
abstract：:Despite the established efficacy of chimeric antigen receptor (CAR) T-cell therapy in hematologic malignancies, translating CAR T therapy to solid tumors has remained investigational. Glioblastoma, the most aggressive and lethal form of primary brain tumor, has recently been among the malignancies being trialed clinic...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-019-00687-3
更新日期：2020-02-01 00:00:00
abstract：:As in all patient populations, epilepsy is common in pregnant women. Consequently, approximately 1 in 200 pregnancies is exposed to antiepileptic drugs (AEDs). Although exposure to AEDs in utero has been associated with an increased risk of major fetal malformations, most women with epilepsy require medication through...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200620100-00001
更新日期：2006-01-01 00:00:00
abstract：BACKGROUND:Refractory status epilepticus (RSE) is an emergency with high mortality requiring neurointensive care. Treatment paradigms include first-generation antiepileptic drugs (AEDs) and anesthetics. Lacosamide (LCM) is a new AED, holding promise as a potent treatment option for RSE. High-level evidence regarding sa...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.1007/s40263-013-0049-y
更新日期：2013-04-01 00:00:00
abstract：:Schizophrenia is a long-term psychiatric disorder that impacts important mental functions and requires indefinite treatment, as well as psychosocial and economic support. The introduction of chlorpromazine, the first antipsychotic, and the subsequent development of a long list of similar dopamine-blocking antipsychoti...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-018-0588-3
更新日期：2019-01-01 00:00:00
abstract：:Teriflunomide is a once-daily oral agent that has been licensed in the EU since August 2013 for the treatment of adult patients with relapsing-remitting multiple sclerosis (RRMS). More recently (September 2014), the EU summary of product characteristics (SmPC) was updated to include data from patients with a first cli...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-015-0299-y
更新日期：2016-01-01 00:00:00
abstract：BACKGROUND:Although levodopa is considered the most effective pharmacotherapy for motor symptoms of Parkinson's disease (PD), chronic use is associated with motor complications, including fluctuating response and unpredictable, involuntary movements called dyskinesia. ADS-5102 (amantadine) extended-release (ER) capsule...
journal_title：CNS drugs
pub_type： 杂志文章,随机对照试验
doi：10.1007/s40263-018-0498-4
更新日期：2018-04-01 00:00:00
abstract：:Oral blonanserin (Lonasen) is an atypical antipsychotic agent indicated for use in patients with schizophrenia in Japan and Korea. It is effective in the treatment of patients with schizophrenia, providing short- and long-term efficacy against both the positive and negative symptoms of the disorder in several randomiz...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/11202620-000000000-00000
更新日期：2010-01-01 00:00:00
abstract：:Major depressive disorder (MDD) is a chronic, recurrent mental disease that causes serious disability. Because currently available antidepressants have limited efficacy with respect to response and remission in patients with MDD, clinicians must choose the best available treatment interventions for patients who do not...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-012-0032-z
更新日期：2013-05-01 00:00:00
abstract：BACKGROUND:Few studies examine predictors of seizures in medically treated patients with epilepsy receiving antiepileptic monotherapy using a large patient population. OBJECTIVE:Our objective was to identify clinical, medication, and demographic factors associated with seizure recurrence in medically treated patients ...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.1007/s40263-014-0191-1
更新日期：2014-11-01 00:00:00
abstract：:Bipolar depression is the predominant abnormal mood state in bipolar disorder. However, despite the key pertinence of this phase of the condition, the focus of research and indeed of clinical interest in the management of bipolar disorder has been mainly on mania. Bipolar depression has been largely neglected, and ear...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200317010-00002
更新日期：2003-01-01 00:00:00
abstract：:The anilidopiperidine opioid remifentanil has pharmacodynamic properties similar to all opioids; however, its pharmacokinetic characteristics are unique. Favourable pharmacokinetic properties, minimally altered by extremes of age or renal or hepatic dysfunction, enable easy titration and rapid dissipation of clinical ...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.2165/00023210-200418150-00004
更新日期：2004-01-01 00:00:00
abstract：:All current antipsychotic drugs block dopamine (DA) receptors, but the nature of the DA dysfunction in schizophrenia has not been clear. However, consistent evidence now shows that presynaptic dopaminergic function is altered in schizophrenia, specifically in terms of increased DA synthesis capacity, baseline synaptic...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-014-0177-z
更新日期：2014-07-01 00:00:00
abstract：:Given the high heritability of the disorder, attention-deficit hyperactivity disorder (ADHD) is common among parents of children with ADHD. Parental ADHD is associated with maladaptive parenting, negative parent-child interaction patterns and a diminished response to behavioural parent training. We describe our previo...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.2165/11633910-000000000-00000
更新日期：2012-09-01 00:00:00
abstract：:Down syndrome (DS), which results from an extra copy of chromosome 21 (trisomy 21), is the most common genetically defined cause of intellectual disability. Although no pharmacotherapy aimed at counteracting the cognitive and adaptive deficits associated with this genetic disorder has been approved at present, there h...
journal_title：CNS drugs
pub_type： 杂志文章,评审
doi：10.1007/s40263-013-0089-3
更新日期：2013-09-01 00:00:00
abstract：BACKGROUND:A recent large database analysis raised concerns of potential acute kidney injury (AKI) risk associated with antipsychotics. However, whether individual atypical and typical antipsychotics are associated with differential AKI risks has not been investigated. OBJECTIVE:The current study compared the risks of...
journal_title：CNS drugs
pub_type： 杂志文章
doi：10.1007/s40263-017-0421-4
更新日期：2017-04-01 00:00:00
